CCL2 and hepatocellular carcinoma: In mouse models, TANs mediate the infiltration of regulatory T (Treg) cells and macrophages in the TME by secreting the chemokines CCL2 and CCL17, leading to the growth of hepatocellular carcinoma cells and increasing the resistance of hepatocellular carcinoma patients to sorafenib (51).